Figure 3.
A. Disease specific (DS) survival of AR+/NE- and AR+/NE+ (amphicrine) tumors in The Cancer Genome Atlas (TCGA) dataset. B. Progression free (PF) survival of AR+/NE- and AR+/NE+ (amphicrine) tumors in the TCGA dataset.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.